EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry.
about
MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor.Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma.EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2.JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms.
P2860
EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
EGF signalling and rapamycin-m ...... ospho-specific flow cytometry.
@ast
EGF signalling and rapamycin-m ...... ospho-specific flow cytometry.
@en
type
label
EGF signalling and rapamycin-m ...... ospho-specific flow cytometry.
@ast
EGF signalling and rapamycin-m ...... ospho-specific flow cytometry.
@en
prefLabel
EGF signalling and rapamycin-m ...... ospho-specific flow cytometry.
@ast
EGF signalling and rapamycin-m ...... ospho-specific flow cytometry.
@en
P2093
P2860
P1476
EGF signalling and rapamycin-m ...... ospho-specific flow cytometry.
@en
P2093
Isabelle Cornez
Joel C Glover
Mrinal Joel
Torunn Berge
P2860
P2888
P356
10.1007/S11060-012-1035-9
P577
2013-01-09T00:00:00Z
P6179
1033693688